Investing News Long-Term Statistics on Lynparza by AstraZeneca/Merck Demonstrate a Benefit for Survival in Ovarian Cancer Patients September 9, 2022
Other Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference September 9, 2022
Investing News AbbVie’s Botox Could Lose Market Share To Revance New Drug After FDA Approval September 8, 2022
Investing News SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment September 7, 2022
Investing News Pacira Achieves Major Objectives, In a Late-Stage Experiment to Broaden the Indication for Local Anesthetics. September 7, 2022
Investing News Roche will pay $250 million upfront to purchase Good Therapeutics in order to expand its immuno-oncology offering September 7, 2022
Investing News Iveric Drives Apellis Lower as Street Responds to Phase 3 Results for the GA Candidate September 6, 2022
Search
